Published online Jan 28, 2024. doi: 10.4329/wjr.v16.i1.20
Peer-review started: October 16, 2023
First decision: November 9, 2023
Revised: December 6, 2023
Accepted: December 25, 2023
Article in press: December 25, 2023
Published online: January 28, 2024
Processing time: 98 Days and 15.7 Hours
Clinical 7-Tesla HASTE was approved for clinical use in 2017. Since then, it has been used widely in specialized research centers mainly for neuroimaging studies. However, it has been also used in the imaging of abdominal organs even though the studies are few.
To summarize all the current evidence concerning the utilization of 7-Tesla MRI in clinical abdominal imaging since to our knowledge there has been no review paper discussing this before.
To offer a comprehensive overview of current literature on clinical abdominal 7T MRI that emphasizes current trends, to summarize the current imaging sequences/parameters used, to describe relevant challenges, and to provide a concise set of potential solutions.
This systematic review adheres to PRISMA guidelines. A PubMed search, utilizing Medical Subject Headings terms such as "7-Tesla" and organ-specific terms, was conducted for articles published between January 1, 1985, and July 25, 2023. Eligibility criteria included studies exploring 7T MRI for imaging human abdominal organs, encompassing various study types (in-vivo/ex-vivo, method development, reviews/meta-analyses). Exclusion criteria involved animal studies and those lacking extractable data. Study selection involved initial identification via title/abstract, followed by a full-text review by two researchers, with discrepancies resolved through discussion. Data extraction covered publication details, study design, population, sample size, 7T MRI protocol, image characteristics, endpoints, and conclusions.
The systematic review encompassed a total of 21 studies. Analysis of the distribution of clinical 7T abdominal imaging studies indicated a predominant emphasis on the prostate (n = 8), followed by the kidney (n = 6), and the hepatobiliary system (n = 5). Research on these organs, as well as the pancreas, demonstrated evident advantages at 7T. Conversely, studies on the small bowel did not reveal significant enhancements compared to traditional MRI at 1.5T. The majority of the evaluated studies originated from Germany (n = 10), followed by the Netherlands (n = 5), the United States (n = 5), Austria (n = 2), the United Kingdom (n = 1), and Italy (n = 1).
7T MRI showcases remarkable imaging potential, however, the limitations arising from inhomogeneous excitation fields underscore the need for ongoing efforts in optimizing dedicated RF coil and pulse design. Continued research and technological advancements are imperative to fully harness the advantages of high magnetic field strengths while addressing the challenges associated with advancements in MRI technology.
More studies are necessary to elucidate the full potential of 7-Tesla MRI in abdominal imaging especially when it comes to the imaging of the pancreas, and the intestines which had very few investigative studies.